CLINICAL_TRIALS
trial_result
· 2015-09-29
Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
Summary
A Phase 2 trial evaluating everolimus in relapsed or refractory mantle cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Swiss Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED